A41
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: - Age = 18 years - Patients undergoing major elective abdominal surgery. - Initial clinical deterioration with suspected infection and admission to the intensive care unit - Need for blood cultures to be taken as part of standard therapy
Exclusion criteria
Exclusion criteria: - Pregnancy - Inclusion in another interventional study - Prior antibiotic therapy beyond usual perioperative prophylaxis (i.e., >24 h) - Refusal to participate in the study
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Concordance of SeptiCyte Rapid® results with clinical diagnosis of Sepsis. | — |
Secondary
| Measure | Time frame |
|---|---|
| - Concordance of SeptiCyte Rapid® results with blood cultures taken at the same time (max. +3h) - Comparison of SeptiCyte Rapid® results with other microbiological findings - Comparison of SeptiCyte Rapid® results with routine clinical infection parameters (e.g. PCT, CRP, leukocyte count) - Impact of SeptiCyte Rapid® on diagnostic costs (descriptive analysis) | — |
Countries
Germany
Contacts
Klinik für Anästhesiologie Universitätsklinikum Heidelberg